- Home
- EU vs QSI Comparison
EU vs QSI Comparison
Compare EU & QSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | EU | QSI |
|---|---|---|
| Founded | 2009 | 2013 |
| Country | United States | United States |
| Employees | N/A | 145 |
| Industry | Other Metals and Minerals | Biotechnology: Pharmaceutical Preparations |
| Sector | Basic Materials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 413.7M | 194.8M |
| IPO Year | 2011 | N/A |
Fundamental Metrics
Financial Performance| Metric | EU | QSI |
|---|---|---|
| Price | $1.87 | $0.95 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 1 | 2 |
| Target Price | ★ $4.00 | $1.00 |
| AVG Volume (30 Days) | 2.1M | ★ 5.4M |
| Earning Date | 05-11-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 11.76 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $43,155,000.00 | N/A |
| Revenue This Year | $212.11 | N/A |
| Revenue Next Year | $29.88 | $618.07 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.52 | $0.69 |
| 52 Week High | $4.19 | $3.10 |
Technical Indicators
Market Signals| Indicator | EU | QSI |
|---|---|---|
| Relative Strength Index (RSI) | 44.02 | 53.69 |
| Support Level | $1.81 | $0.90 |
| Resistance Level | $2.17 | $1.10 |
| Average True Range (ATR) | 0.13 | 0.09 |
| MACD | -0.00 | 0.00 |
| Stochastic Oscillator | 16.00 | 46.97 |
Price Performance
Historical ComparisonAbout EU enCore Energy Corp.
enCore Energy Corp together with its subsidiary, is principally engaged in the acquisition, exploration, development and extraction of uranium resource properties in the United States. The Company is focused on the extraction of domestic uranium in the United States. The Company utilizes the In-Situ Recovery technology (ISR) to provide necessary fuel for the generation of clean, reliable, and carbon-free nuclear energy.
About QSI Quantum-Si Incorporated
Quantum-Si Inc is a life sciences company focused on proteomics research and analytical technologies. It develops single-molecule detection platforms designed to enable next-generation protein sequencing (NGPS) and large-scale protein analysis. Its technology supports massively parallel sequencing of proteins and can also be applied to the study of nucleic acids, providing tools for researchers and clinical applications in molecular analysis. The company's revenue is derived from sales of products and services.